Healthcare provider profile · identity verified

Stephen Cleve Scarseth, NP

Nurse Practitioner · CANDOR, NY · NPI 1508071754

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	415	126
Levothyroxine Sodium	Levothyroxine Sodium	325	83
Omeprazole	Omeprazole	256	72
Amlodipine Besylate	Amlodipine Besylate	223	84
Lisinopril	Lisinopril	207	68
Metoprolol Succinate	Metoprolol Succinate	167	57
Pantoprazole Sodium	Pantoprazole Sodium	163	55
Rosuvastatin Calcium	Rosuvastatin Calcium	122	44
Albuterol Sulfate Hfa	Albuterol Sulfate	121	41
Eliquis	Apixaban	119	34
Paroxetine Hcl	Paroxetine Hcl	112	33
Metformin Hcl	Metformin Hcl	110	35
Tamsulosin Hcl	Tamsulosin Hcl	99	27
Gabapentin	Gabapentin	95	26
Ibuprofen	Ibuprofen	95	35
Simvastatin	Simvastatin	94	31
Fluticasone Propionate	Fluticasone Propionate	88	29
Losartan Potassium	Losartan Potassium	85	29
Clonazepam	Clonazepam	83	15
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	72	19
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	70	26
Carvedilol	Carvedilol	69	25
Allopurinol	Allopurinol	67	21
Prednisone	Prednisone	67	49
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	65	49
Doxycycline Hyclate	Doxycycline Hyclate	64	51
Metformin Hcl Er	Metformin Hcl	62	18
Pregabalin	Pregabalin	60	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	58	24
Nifedipine Er	Nifedipine	57	14
Sertraline Hcl	Sertraline Hcl	56	17
Montelukast Sodium	Montelukast Sodium	55	17
Pioglitazone Hcl	Pioglitazone Hcl	55	21
Finasteride	Finasteride	52	15
Alprazolam	Alprazolam	50	15
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	50	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	50	16
Famotidine	Famotidine	49	15
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	46	20
Zolpidem Tartrate	Zolpidem Tartrate	43	suppressed
Potassium Chloride	Potassium Chloride	42	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	41	suppressed
Furosemide	Furosemide	40	19
Alendronate Sodium	Alendronate Sodium	38	13
Trazodone Hcl	Trazodone Hcl	38	12
Fluconazole	Fluconazole	37	24
Azithromycin	Azithromycin	35	27
Clopidogrel	Clopidogrel Bisulfate	35	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	35	12
Pravastatin Sodium	Pravastatin Sodium	35	14
Citalopram Hbr	Citalopram Hydrobromide	34	11
Meclizine Hcl	Meclizine Hcl	34	14
Atenolol	Atenolol	33	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	33	11
Duloxetine Hcl	Duloxetine Hcl	32	11
Fluoxetine Hcl	Fluoxetine Hcl	32	11
Meloxicam	Meloxicam	32	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	31	suppressed
Synthroid	Levothyroxine Sodium	31	12
Ciprofloxacin Hcl	Ciprofloxacin Hcl	30	25
Jardiance	Empagliflozin	30	11
Sildenafil Citrate	Sildenafil Citrate	30	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	29	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	29	suppressed
Glimepiride	Glimepiride	29	11
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	28	14
Verapamil Er	Verapamil Hcl	28	suppressed
Xarelto	Rivaroxaban	28	suppressed
Celecoxib	Celecoxib	27	11
Ketoconazole	Ketoconazole	27	13
Ventolin Hfa	Albuterol Sulfate	27	suppressed
Arexvy	Rsvpref3 Antigen/As01e/Pf	26	26
Diazepam	Diazepam	26	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	26	suppressed
Clindamycin Hcl	Clindamycin Hcl	25	18
Levetiracetam	Levetiracetam	25	suppressed
Glipizide	Glipizide	24	suppressed
Ibu	Ibuprofen	24	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	24	suppressed
Spironolactone	Spironolactone	24	suppressed
Aripiprazole	Aripiprazole	23	suppressed
Ozempic	Semaglutide	23	suppressed
Valsartan	Valsartan	23	suppressed
Nebivolol Hcl	Nebivolol Hcl	22	suppressed
Tramadol Hcl	Tramadol Hcl	22	suppressed
Tizanidine Hcl	Tizanidine Hcl	21	suppressed
Bupropion Xl	Bupropion Hcl	20	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	20	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	20	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	20	17
Valacyclovir	Valacyclovir Hcl	20	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	19	suppressed
Lovastatin	Lovastatin	18	suppressed
Naproxen	Naproxen	18	suppressed
Symbicort	Budesonide/Formoterol Fumarate	18	suppressed
Torsemide	Torsemide	18	suppressed
Januvia	Sitagliptin Phosphate	17	suppressed
Oxycodone Hcl	Oxycodone Hcl	17	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	16	suppressed
Ramipril	Ramipril	16	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	15	suppressed
Ezetimibe	Ezetimibe	15	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	15	suppressed
Rizatriptan	Rizatriptan Benzoate	15	suppressed
Ropinirole Hcl	Ropinirole Hcl	15	suppressed
Tresiba Flextouch U-100	Insulin Degludec	15	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	14	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	14	11
Warfarin Sodium	Warfarin Sodium	14	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	13	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	13	suppressed
Enalapril Maleate	Enalapril Maleate	13	suppressed
Ondansetron Hcl	Ondansetron Hcl	13	suppressed
Risperidone	Risperidone	13	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	13	suppressed
Trulicity	Dulaglutide	13	suppressed
Vilazodone Hcl	Vilazodone Hcl	13	suppressed
Eszopiclone	Eszopiclone	12	suppressed
Farxiga	Dapagliflozin Propanediol	12	suppressed
Nystatin	Nystatin	12	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	12	suppressed
Vraylar	Cariprazine Hcl	12	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	11	suppressed
Lithium Carbonate	Lithium Carbonate	11	suppressed
Myrbetriq	Mirabegron	11	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	11	suppressed
Solifenacin Succinate	Solifenacin Succinate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error